pharmaphorum July 23, 2021
If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down. As the field becomes more crowded, digital tools may be critical for improving outcomes, says a new whitepaper.
The whitepaper, ‘The Role of Digital Health in Immuno-oncology Therapy Development and Adoption’ from BrightInsight, highlights the many ways in which digital can realise and accelerate the impact of innovative immuno-oncology (IO) therapies.
It says that the growth in treatment options is making it more difficult for oncologists to match patients to the right therapy – but there are...
Today's Sponsors
Today's Sponsor